Lannett receives FDA approval for generic Ionamin
PHILADELPHIA — The Food and Drug Administration has approved a generic version of a short-term adjunct treatment for obesity.
Lannett said that the FDA approved its abbreviated new drug application for phentermine resin extended-release capsules in the 15-mg and 30-mg strengths. The drug, which is equivalent to UCB’s Ionamin, will be sold in bariatric clinics.
Lannett’s wholly owned pain management subsidiary, Cody Labs, will produce the active pharmaceutical ingredient for this product. The drug is indicated in the management of exogenous obesity, a form of obesity caused by excessive food intake.
Strides Arcolab’s generic diabetes drug enters market
BANGALORE, India — The Food and Drug Administration has approved a generic drug for diabetes made by Indian generic drug maker Strides Arcolab.
The FDA approved acarbose tablets in the 25-mg, 50-mg and 100-mg strengths. The drug is a niche drug used to treat Type 2 diabetes, Strides said.
Acarbose tablets have sales of about $21 million, according to IMS Health.
Human antibody may protect against all influenza A viruses
NEW YORK — Researchers have found a human antibody that may be able to protect against all influenza A viruses, according to published reports.
The antibody, FI6, could lead to the development of a universal flu vaccine because it targets groups 1 and 2, the two main groups of the influenza A virus. Previously, researchers had not been able to find an antibody that worked against both groups.
The researchers have found the antibody effective in mice and ferrets, according to the reports.